FDA Grants Fast Track Status to Amplia Therapeutics’ Narmafotinib Amplia Therapeutics, a biotech company located in Melbourne, has obtained Fast Track Designation from the US Food and Drug Administration (FDA) for its primary product candidate, narmafotinib. This recognition marks a pivotal moment, as it speeds up the regulatory assessment pathway, potentially reducing the drug’s time to reach the market.

Sks Technologies obtains million data centre agreement SKS Technologies (ASX: SKS) has landed a substantial million agreement for a data centre initiative in Melbourne. This contract was granted by Erilyan Projects, a construction firm with which SKS Technologies has a longstanding partnership.

Fisker Group and Auto Parts Manufacturers Encounter Financial Struggles The automotive sector is experiencing significant financial turmoil, with numerous prominent companies opting for Chapter 11 bankruptcy in 2024. Fisker Group, an electric vehicle (EV) producer located in Manhattan Beach, California, became the first car manufacturer to pursue Chapter 11 protection this year, filing on June 18.

Carnival’s Reaction to Hurricane Ernesto In August, Carnival Cruise Line encountered a major operational hurdle as Hurricane Ernesto approached Grand Turk. The *Carnival Magic* was at the port, but with the impending storm, the cruise line was compelled to make the vital choice to evacuate ahead of schedule.

Ford alters direction towards hybrids amid EV hurdles In the previous month, Ford executed a notable shift in its electric vehicle (EV) strategy, surprising both supporters and detractors. The manufacturer revealed a pivot from its ambitious objective of a completely electric range, instead deciding to concentrate on hybrid models.